Menu

Pharmaceutical Litigation

855-797-9899

Pharmaceutical Litigation

Complications
after taking
Xarelto®?

Find out if you qualify
for legal recourse through
a FREE, private and no
obligation
case review by our Pharma Suits
patient advocates.

Free Case Review




Xarelto and the Risk of Strokes


Stroke occurs when the blood flow to the brain is reduced or interrupted, depriving the tissue of oxygen and nutrients and destroying brain cells. Although anti-coagulant (blood-thinning) medication Xarelto was designed to help reduce the risk stroke in patients with atrial fibrillation (irregular heartbeat) and to treat and prevent blood clots, recent evidence indicates that it may actually increase the risk of stroke in some patients.

In its short time on the market since its approval by FDA on July 1, 2011, Xarelto has been linked to a number of severe and potentially life-threatening side effects. Hundreds of people have filed lawsuits against the manufacturers, Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc., after suffering serious injuries with this drug.

If you or your loved one has suffered a stroke or other injuries caused by Xarelto, it is important that you speak with a knowledgeable attorney as soon as possible. Our Xarelto lawyers at Farah & Farah are currently investigating Xarelto cases nationwide. We our dedicated to representing individuals who have been injured by dangerous drugs and devices.

Symptoms of Stroke

In cases of stroke, it is important to act fast and seek emergency medical attention immediately. Be alert to the symptoms of stroke, and note the time when they first appeared, as that could be a factor in determining treatment. Symptoms of stroke may include:

  • Difficulty speaking and understanding, which may include slurring of words;
  • Numbness or paralysis of the face, an arm, or a leg, particularly on one side of the body;
  • Blurred or blackened vision in one or both eyes, or seeing double;
  • Sudden severe headache, which may be accompanied by vomiting, dizziness, or altered consciousness; and
  • Difficulty walking, such stumbling, dizziness, or loss of balance or coordination.

Facts about Stroke

As reported by the Centers for Disease Control and Prevention (CDC):

  • Nearly 130,000 people die from stroke every year in the U.S.
  • Stroke causes 1 out of every 20 deaths in America.
  • More than 795,000 Americans a year suffer a stroke.

According to the Mayo Clinic, stroke can be ischemic (when the arteries to the brain are narrowed or blocked by blood clots) or hemorrhagic (when blood vessels in the brain leak or rupture). While Xarelto is designed to help prevent ischemic stroke by reducing the formation of blood clots, it may increase the risk of hemorrhagic stroke by causing bleeding in the brain.

Hemorrhagic stroke can occur in different ways and in different locations in the brain:

  • Subarachnoid Hemorrhage: This occurs when an artery bursts on or near the surface of the brain, spilling blood between the brain surface and the skull. This type of hemorrhage is often accompanied by a sudden, severe headache. It is typically caused by the bursting of an aneurysm — an abnormal, blood-filled bulge in an artery.
  • Intracerebral Hemorrhage: With this type of hemorrhagic stroke, a blood vessel bursts inside the brain, spilling blood into the surrounding brain tissue and damaging cells. Brain cells beyond the leak in the blood vessel are deprived of blood flow and also damaged. Mayo Clinic names the use of blood-thinning medications as a cause of this type of brain hemorrhage and stroke.

Documented Hemorrhagic Stroke Caused by Xarelto

The National Institutes of Health (NIH) published a case of intracranial hemorrhage associated with rivaroxaban (Xarelto) in July 2014. The patient was a 92-year old man who had been on warfarin (a different anti-coagulant medication) for many years. The patient had difficulty swallowing the warfarin capsule, so his doctor switched him to Xarelto. Four months later, this patient was admitted to the ICU after a stroke and intracranial hemorrhage, which researchers determined was caused by Xarelto.

In the discussion of this study, researchers state that certain characteristics of rivaroxaban (Xarelto) may prevent the wide application of this drug. They refer to the EINSTEIN DVT, PE, and Extension clinical trials of Xarelto, in which a higher incidence of both thrombotic (blood clots) and bleeding events was found in patients over the age of 65.

Xarelto Stroke Attorneys Investigating Drug Injury Cases

At Farah & Farah, we believe that big drug companies that put profit before personal safety should be held accountable for the harm their products cause. We also believe that injured victims of dangerous drugs should not have to suffer in silence.

If you or a family member has suffered a stroke or other serious side effect of Xarelto, contact our Xarelto stroke attorneys at (800) 533-3555 for a free case consultation. We will be happy to evaluate your case and assess the damages you may be entitled to claim.


 

Need help now? Speak with a
Patient Advocate now:
855-797-9899

Who We Are

The pharmaceutical litigation attorneys at Farah & Farah go after negligent corporations that put unsuspecting consumers in harm's way. Pharmaceutical companies not only have a duty to manufacture drugs that are safe, but they also have the obligation to warn consumers regarding dangerous side effects that can be caused by these drugs.

Learn More